• 1
    Preusser M, de Ribaupierre S, Wohrer A, et al. Current concepts and management of glioblastoma. Ann Neurol. 2011;70:9-21.
  • 2
    Stupp R, Hegi ME, Gilbert MR, Chakravarti A. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol. 2007;25:4127-4136.
  • 3
    Mishel MH. Uncertainty in illness. Image J Nurs Sch. 1988;20:225-232.
  • 4
    Lin L, Acquaye AA, Vera-Bolanos E, Cahill JE, Gilbert MR, Armstrong TS. Uncertainty in patients with primary brain tumors (PBT) [abstract]. Neuro-Oncology. 2012;14(suppl 6):157. Abstract SM-20.
  • 5
    Brandes AA, Tosoni A, Spagnolli F, et al. Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro Oncol. 2008;10:361-367.
  • 6
    Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008;9:453-461.
  • 7
    Cordova MJ, Andrykowsky MA, Kenady DE, McGrath PC, Sloan DA, Redd WH. Frequency and correlations of posttraumatic-stress-disorder-like-symptoms after treatment for breast cancer. J Consult Clin Psychol. 1995;63:981-986.
  • 8
    Mishel MH. Uncertainty in chronic illness. Annu Rev Nurs Res. 1999;17:269-294.
  • 9
    Lin L, Acquaye AA, Vera-Bolanos E, Cahill JE, Gilbert MR, Armstrong TS. Validation of the Mishel's Uncertainty in Illness Scale-Brain Tumor Form (MUIS-BT). J Neurooncol. 2012;110:293-300.
  • 10
    Mishel MH, Clayton MF. Theories of uncertainty in illness. In: Smith MJ, Liehr PR, eds. Middle Range Theory for Nursing. 2nd ed. New York: Springer; 2008, pp. 55–84.
  • 11
    Lin L, Acquaye AA, Vera-Bolanos E, Cahill J, Gilbert MR, Armstrong TS. Uncertainty in patients with primary brain tumors [abstract]. Neuro-Oncology. 2011;13(suppl 3):124. Abstract QL-14.
  • 12
    Mishel MH. The measurement of uncertainty in illness. Nurs Res. 1981;30:258-263.
  • 13
    Mishel MH. Perceived uncertainty and stress in illness. Res Nurs Health. 1984;7:163-171.
  • 14
    Mishel MH, Braden CJ. Uncertainty: a mediator between support and adjustment. West J Nurs Res. 1987;9:43-57.
  • 15
    Armstrong TS, Mendoza T, Gring I, et al. Validation of the M. D Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol. 2006;80:27-35.
  • 16
    McNair DM, Lorr M, Droppleman LF. Educational and Industrial Testing Service Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service; 1971.
  • 17
    Shacham S. A shortened version of the Profile of Mood States. J Pers Assess. 1983;47:305-306.
  • 18
    Baker F, Denniston M, Zabora J, Polland A, Dudley WN. A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology. 2002;11:273-281.
  • 19
    Muthen LK, Muthen BO. Mplus: Statistical Analysis With Latent Variables (version 5.1) [computer software]. Los Angeles, CA: Muthen & Muthen; 2008.
  • 20
    Sousa KH, Kwok O-M. Putting Wilson and Cleary to the test: analysis of a HRQOL conceptual model using structural equation modeling. Qual Life Res. 2006;15:725-737.
  • 21
    MacCallum RC, Browne MW, Sugawara HM. Power analysis and determination of sample size for covariance structure modeling. Psychol Methods. 1996;1:130-149.
  • 22
    Hu L, Bentler PM. Fit indices in covariance structure modeling: sensitive to underparameterization model misspecification. Psychol Methods. 1998;3:424-453.
  • 23
    Hu L, Bentler PM. Cutoff criteria for fit indices in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling. 1999;6:1-55.